Alx Oncology Holdings Inc ALXO

NAS: ALXO | ISIN: US00166B1052 28/05/2025

0,448 USD (-0,04%)

(-0,04%) 28/05/2025

Toon enkel gratis nieuws

8 maart 2025 · Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge · Persbericht

4 oktober 2023 · Thinking about buying stock in ALX Oncology Holdings, RedHill Biopharma, Freeline Therapeutics Holdings, Terawulf, or I-Mab? · Persbericht

14 maart 2023 · ALX Oncology and Quantum Leap Healthcare CollaborativeTM Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer · Persbericht

16 augustus 2022 · ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce the Selection of Evorpacept in the I-SPY-P1 TRIAL in Combination with Enhertu® in Breast Cancer · Persbericht

14 december 2021 · DURECT Corporation Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia · Persbericht

14 september 2021 · Lightstone Ventures Raises $375 Million Fund · Persbericht

18 maart 2021 · ALX Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones · Persbericht

11 januari 2021 · ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe